in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Dishman Signs API Development Deal with Polish Firm
4:51 AM MDT | March 25, 2009 | Deepti Ramesh
Dishman Pharmaceuticals & Chemicals (Ahmedabad, India) says it has signed a cooperation and joint active pharmaceuticals ingredients (API) development agreement with Polpharma (Starogard GdaĆski, Poland), a manufacturer of APIs and finished dosage forms. Polpharma is a strong player in its home market and a leader in the Central and Eastern European markets and Commonwealth of Independent States (CIS) countries, Dishman says. “Such partnerships will ensure long term API manufacturing contracts to Dishman and also provide API development and DMF (drug...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee